Changeflow GovPing Pharma & Drug Safety EPO Patent Publication: Phyto-Compositions
Routine Notice Added Final

EPO Patent Publication: Phyto-Compositions

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Published March 18th, 2026
Detected March 25th, 2026
Email

Summary

The European Patent Office published patent application EP4661839A1 for Phyto-Compositions on March 18, 2026. The applicant is Phytoheal Medtech International. This publication details new compositions and their potential applications.

What changed

The European Patent Office (EPO) has published patent application EP4661839A1 concerning 'Phyto-Compositions', with a publication date of March 18, 2026. The application was filed by Phytoheal Medtech International and includes various International Patent Classification (IPC) codes related to medicinal preparations, plant-based active ingredients, and cosmetic compositions, particularly for skin treatment.

This publication represents the grant of a patent, not a new regulatory requirement. Companies operating in the pharmaceutical, cosmetic, or biotechnology sectors within the designated European states should note this patent for intellectual property considerations. No immediate compliance actions are required for entities not involved in the development or commercialization of these specific patented compositions.

Source document (simplified)

← EPO Patent Bulletin

PHYTO-COMPOSITIONS

Publication EP4661839A1 Kind: A1 Mar 18, 2026

Applicants

PHYTOHEAL MEDTECH INTERNATIONAL

Inventors

BOGONI, Sebastiano Stefano Giuseppe, ANGILELLA, Daniele, POLIMENO, Tiziana Rosa Natalina

IPC Classifications

A61K 9/00 20060101AFI20240816BHEP A61K 35/74 20150101ALI20240816BHEP A61K 36/03 20060101ALI20240816BHEP A61K 36/07 20060101ALI20240816BHEP A61K 36/185 20060101ALI20240816BHEP A61K 36/48 20060101ALI20240816BHEP A61K 36/481 20060101ALI20240816BHEP A61K 36/704 20060101ALI20240816BHEP A61K 36/87 20060101ALI20240816BHEP A61P 17/00 20060101ALI20240816BHEP A61K 8/73 20060101ALI20240816BHEP A61K 8/9711 20170101ALI20240816BHEP A61K 8/9789 20170101ALI20240816BHEP A61Q 17/00 20060101ALI20240816BHEP A61Q 19/00 20060101ALI20240816BHEP A61P 17/02 20060101ALI20240816BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Applicants Inventors IPC Classifications Designated States

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4661839A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Labeling Product Development
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Intellectual Property Medical Devices

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.